Cohen CJ - Search Results

1

Enhanced antitumor activity mediated by human 4-1BB-engineered T cells.

Daniel-Meshulam I, Horovitz-Fried M, Cohen CJ. Daniel-Meshulam I, et al. Among authors: cohen cj. Int J Cancer. 2013 Dec 15;133(12):2903-13. doi: 10.1002/ijc.28320. Epub 2013 Jul 16. Int J Cancer. 2013. PMID: 23754772

2

Selected murine residues endow human TCR with enhanced tumor recognition.

Bialer G, Horovitz-Fried M, Ya'acobi S, Morgan RA, Cohen CJ. Bialer G, et al. Among authors: cohen cj. J Immunol. 2010 Jun 1;184(11):6232-41. doi: 10.4049/jimmunol.0902047. Epub 2010 Apr 28. J Immunol. 2010. PMID: 20427762

3

Genetically modulating T-cell function to target cancer.

Merhavi-Shoham E, Haga-Friedman A, Cohen CJ. Merhavi-Shoham E, et al. Among authors: cohen cj. Semin Cancer Biol. 2012 Feb;22(1):14-22. doi: 10.1016/j.semcancer.2011.12.006. Epub 2011 Dec 24. Semin Cancer Biol. 2012. PMID: 22210183 Review.

4

Incorporation of transmembrane hydrophobic mutations in the TCR enhance its surface expression and T cell functional avidity.

Haga-Friedman A, Horovitz-Fried M, Cohen CJ. Haga-Friedman A, et al. Among authors: cohen cj. J Immunol. 2012 Jun 1;188(11):5538-46. doi: 10.4049/jimmunol.1103020. Epub 2012 Apr 27. J Immunol. 2012. PMID: 22544927

5

How (specific) would like your T-cells today? Generating T-cell therapeutic function through TCR-gene transfer.

Daniel-Meshulam I, Ya'akobi S, Ankri C, Cohen CJ. Daniel-Meshulam I, et al. Among authors: cohen cj. Front Immunol. 2012 Jul 6;3:186. doi: 10.3389/fimmu.2012.00186. eCollection 2012. Front Immunol. 2012. PMID: 22783259 Free PMC article.

6

Human T cells engineered to express a programmed death 1/28 costimulatory retargeting molecule display enhanced antitumor activity.

Ankri C, Shamalov K, Horovitz-Fried M, Mauer S, Cohen CJ. Ankri C, et al. Among authors: cohen cj. J Immunol. 2013 Oct 15;191(8):4121-9. doi: 10.4049/jimmunol.1203085. Epub 2013 Sep 11. J Immunol. 2013. PMID: 24026081

7

An NCR1-based chimeric receptor endows T-cells with multiple anti-tumor specificities.

Tal Y, Yaakobi S, Horovitz-Fried M, Safyon E, Rosental B, Porgador A, Cohen CJ. Tal Y, et al. Among authors: cohen cj. Oncotarget. 2014 Nov 15;5(21):10949-58. doi: 10.18632/oncotarget.1919. Oncotarget. 2014. PMID: 25431955 Free PMC article.

8

Nanomedicine for Cancer Immunotherapy: Tracking Cancer-Specific T-Cells in Vivo with Gold Nanoparticles and CT Imaging.

Meir R, Shamalov K, Betzer O, Motiei M, Horovitz-Fried M, Yehuda R, Popovtzer A, Popovtzer R, Cohen CJ. Meir R, et al. Among authors: cohen cj. ACS Nano. 2015 Jun 23;9(6):6363-72. doi: 10.1021/acsnano.5b01939. Epub 2015 Jun 11. ACS Nano. 2015. PMID: 26039633

9

Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes.

Cohen CJ, Gartner JJ, Horovitz-Fried M, Shamalov K, Trebska-McGowan K, Bliskovsky VV, Parkhurst MR, Ankri C, Prickett TD, Crystal JS, Li YF, El-Gamil M, Rosenberg SA, Robbins PF. Cohen CJ, et al. J Clin Invest. 2015 Oct 1;125(10):3981-91. doi: 10.1172/JCI82416. Epub 2015 Sep 21. J Clin Invest. 2015. PMID: 26389673 Free PMC article.

10

Durable Complete Response from Metastatic Melanoma after Transfer of Autologous T Cells Recognizing 10 Mutated Tumor Antigens.

Prickett TD, Crystal JS, Cohen CJ, Pasetto A, Parkhurst MR, Gartner JJ, Yao X, Wang R, Gros A, Li YF, El-Gamil M, Trebska-McGowan K, Rosenberg SA, Robbins PF. Prickett TD, et al. Among authors: cohen cj. Cancer Immunol Res. 2016 Aug;4(8):669-78. doi: 10.1158/2326-6066.CIR-15-0215. Epub 2016 Jun 16. Cancer Immunol Res. 2016. PMID: 27312342 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

352 results

Search Page

Filters